» Articles » PMID: 32919911

Systematic Review on the Prevalence of Nonalcoholic Fatty Liver Disease in South Korea

Overview
Specialty Gastroenterology
Date 2020 Sep 13
PMID 32919911
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: We aimed to conduct a systematic review and a meta-analysis to estimate NAFLD prevalence and its change in Korea.

Methods: We searched the literature involving NAFLD prevalence in Korea in PubMed, RISS, and KMBASE from inception to June 2017. Studies with subjects with certain disorders, population limitations, or subjects who consume alcohol were excluded. Analysis was stratified by publication year, age, gender, severity, body mass index (BMI), and diagnostic technique. Random-effects models were used to provide point estimates (95% confidence interval) of prevalence with subgroup analysis to account for heterogeneity.

Results: A total of 61 studies (837,897 participants) were included. The overall NAFLD prevalence in Korea was 30.3% (men: 41.1%, women: 20.3%), with a slight increase from 29.0% to 31.0% over an approximately 10-year period. BMI significantly affected NAFLD prevalence (≤ or > 25 kg/m, 12.3% vs. 41.7%, p < 0.001), while women were significantly affected by aging (< or ≥ 50 years, 17.0% vs. 25.8%, p < 0.01). The prevalence of steatosis by severity was 22.6% for mild, 9.8% for moderate to severe and 2.2% for nonalcoholic steatohepatitis (NASH), with different patterns by gender.

Conclusion: The current study is the first systematic analysis on NAFLD prevalence in Korea and found a change in NAFLD prevalence during the recent decade.

Citing Articles

Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults.

Lee J, Han C, Lee D, Sung P, Bae S, Yang H Gut Liver. 2024; 19(1):116-125.

PMID: 39639749 PMC: 11736320. DOI: 10.5009/gnl240323.


High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction.

Baek S, Yoon J Biomolecules. 2024; 14(11).

PMID: 39595644 PMC: 11591830. DOI: 10.3390/biom14111468.


Pea Albumin Alleviates Oleic Acid-Induced Lipid Accumulation in LO2 Cells Through Modulating Lipid Metabolism and Fatty Acid Oxidation Pathways.

Fang B, Luo J, Cui Z, Liu R, Wang P, Zhang J Foods. 2024; 13(21).

PMID: 39517266 PMC: 11545291. DOI: 10.3390/foods13213482.


Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study.

Lee J, So J, Han C, Yang H, Sung P, Bae S Hepatol Int. 2024; 19(1):181-190.

PMID: 39394385 DOI: 10.1007/s12072-024-10737-8.


8-Prenylgenistein Isoflavone in Cheonggukjang Acts as a Novel AMPK Activator Attenuating Hepatic Steatosis by Enhancing the SIRT1-Mediated Pathway.

Arulkumar R, Jin Jung H, Noh S, Kim H, Young Chung H Int J Mol Sci. 2024; 25(17).

PMID: 39273677 PMC: 11395689. DOI: 10.3390/ijms25179730.